Corient Private Wealth LP Acquires New Stake in Agilent Technologies, Inc. $A

Posted by George Bondi on Aug 28th, 2026

Corient Private Wealth LP acquired a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 243,555 shares of the medical research company’s stock, valued at approximately $32,352,000. Corient Private Wealth LP owned 0.09% of Agilent Technologies as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of A. Brighton Jones LLC raised its holdings in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after purchasing an additional 769 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares in the last quarter. Acadian Asset Management LLC increased its position in Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in Agilent Technologies during the 2nd quarter worth approximately $273,000.

Agilent Technologies Stock Performance

A opened at $157.60 on Friday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The stock has a market cap of $44.51 billion, a P/E ratio of 31.02, a P/E/G ratio of 2.74 and a beta of 1.25. The stock’s 50 day simple moving average is $139.76 and its 200 day simple moving average is $126.85. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A – Get Free Report) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the business earned $1.37 earnings per share. Agilent Technologies’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target for the company. Morgan Stanley increased their price objective on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. JPMorgan Chase & Co. raised their target price on Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a report on Thursday. TD Cowen boosted their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $170.33.

View Our Latest Report on A

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.